1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCI-P120-9801, MSKCC-00088, UCLA-9808021, NCI-V98-1470, NCT00003563
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0302038, PCI-P-PCYC-0211, NCT00054795
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCI-P120-9501, NCI-V96-0844
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: NU-02H8, NU-0228-024, PCI-P-PCYC-0213, NCT00089284
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0223, NCT00290004
|
|
6.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-01051, PCI-PCYC-0206, NCI-G01-1999, NCT00022256
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0216, NCT00076401
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0221, NCT00086034
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0215, NCT00096837
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0222, NCT00100711
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0224, NCT00121420
|
|
12.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0227, NCT00129844
|
|
13.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0219, NCT00134186
|
|
14.
|
Phase: Phase II Type: Treatment Status: Closed Age: 21 and under at diagnosis Sponsor: NCI Protocol IDs: COG-ACNS0222, ACNS0222, NCT00387790
|
|
15.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0228, NCT00365183
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCYC-0229, NCT00373204
|
|
17.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PCI-P120-9401, NCI-V96-0841
|
|
18.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCLA-HSPC-970904203, COOPER-RP-97-126, LAC-USC-6G971, UCD-RW-98-01, UCLA-HSPC-970904201, UCLA-HSPC-970904202, NCI-T97-0108, NCT00003409, T97-0108
|
|
19.
|
Phase: Phase I Type: Diagnostic, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCLA-HSPC-970904303, UCLA-HSPC-970904301, UCLA-HSPC-970904302, NCI-T97-0107, NCT00003410, T97-0107
|
|
20.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: PCI-97-108, NCI-T97-0109, NCT00003411, T97-0109
|
|
21.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-98062407, NCI-T97-0115, NCT00003798, T97-0115
|
|
22.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NABTT-9712, JHOC-NABTT-9712, NCT00006452
|
|
23.
|
Phase: Phase I Type: Treatment Status: Completed Age: 21 and under Sponsor: NCI Protocol IDs: COG-A09712, CCG-09712, NCT00003909, A09712
|
|
24.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: OSU-9976, OSU-99H0239, NCI-T99-0041, NCT00004262, T99-0041
|
|
25.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: OSU-0003, OSU-99H0355, OSU-T99-0073, NCI-T99-0073, NCT00005065, T99-0073
|